Nutritive compositions and methods of using same

A dosage form comprising

• a) between 10 and 50 g of dextrose;
• and
• b) between 30 and 120 g of amino acids;
• wherein the dextrose and the amino acids are dissolved in between 100 mL and 2 L of aqueous solution, and wherein the solution is contained within a sterile container, wherein the sterile container is suitable for parenteral administration of the aqueous solution.

A method of treating malnutrition in a hemodialysis patient in need thereof comprising determining a body mass of the patient, wherein if the body mass of the patient is between 34 and 39 kg, the patient is parenterally administered about 20 g of dextrose and about 51 g of amino acids in about 334 mL of solution;

• wherein if the body mass of the patient is between 40 and 44 kg, the patient is parenterally administered about 23 g of dextrose and about 60 g of amino acids in about 383 mL of solution;
• wherein if the body mass of the patient is between 45 and 51 kg, the patient is parenterally administered about 26 g of dextrose and about 68 g of amino acids in about 427 mL of solution;
• wherein if the body mass of the patient is between 52 and 59 kg, the patient is parenterally administered about 30 g of dextrose and about 78 g of amino acids in about 483 mL of solution;
• wherein if the body mass of the patient is between 60 and 69 kg, the patient is parenterally administered about 35 g of dextrose and about 90 g of amino acids in about 550 mL of solution;
• and wherein if the body mass of the patient is above 70 kg, the patient is parenterally administered about 41 g of dextrose and about 105 g of amino acids in about 635 mL of solution;
• thereby treating malnutrition in the hemodialysis patient in need thereof.

A dosage form comprising:

• a) about 20 g of dextrose;
• and
• b) about 51 g of amino acids;
• wherein the dextrose and amino acids are dissolved in an aqueous solution of about 334 mL in volume and wherein the dosage form is contained in a sterile container appropriate for parenteral administration of the aqueous solution to a human patient.

A dosage form comprising:

• a) about 23 g of dextrose;
• and
• b) about 60 g of amino acids;
• wherein the dextrose and amino acids are dissolved in an aqueous solution of about 383 mL in volume and wherein the dosage form is contained in a sterile container appropriate for parenteral administration of the aqueous solution to a human patient.

A dosage form comprising:

• a) about 26 g of dextrose;
• and
• b) about 68 g of amino acids;
• wherein the dextrose and amino acids are dissolved in an aqueous solution of about 427 mL in volume and wherein the dosage form is contained in a sterile container appropriate for parenteral administration of the aqueous solution to a human patient.

A dosage form comprising:

• a) about 30 g of dextrose;
• and
• b) about 78 g of amino acids;
• wherein the dextrose and amino acids are dissolved in an aqueous solution of about 483 mL in volume and wherein the dosage form is contained in a sterile container appropriate for parenteral administration of the aqueous solution to a human patient.

A dosage form comprising:

• a) about 35 g of dextrose;
• and
• b) about 90 g of amino acids;
• wherein the dextrose and amino acids are dissolved in an aqueous solution of about 550 mL in volume and wherein the dosage form is contained in a sterile container appropriate for parenteral administration of the aqueous solution to a human patient.

A dosage form comprising:

• a) about 41 g of dextrose;
• and
• b) about 105 g of amino acids;
• wherein the dextrose and amino acids are dissolved in an aqueous solution of about 635 mL in volume and wherein the dosage form is contained in a sterile container appropriate for parenteral administration of the aqueous solution to a human patient.